Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03707 |
| Species: | Homo sapiens |
| Position : | chr2:223164458-223165065 |
| Year: | 2016 |
| Title: | FOXD3 Promotes PAX3 Expression in Melanoma Cells. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | melanoma |
| PMID: | 26252164 |
| MONDO: | MONDO:0005105 |
| Tissue: | skin of body |
| Tissue Ontology ID: | UBERON:0002097 |
| Cell Source: | SK-MEL-28 |
| CVCL ID: | CVCL_0526 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay; TF binding assay; Functional perturbation assay |
| Low Throughput Method: | Phylogenetic footprinting; Luciferase Reporter Assay; EMSA; ChIP-qPCR; FOXD3 overexpression; dominant-negative FOXD3; RT-qPCR; Western blot |
| Target gene : | PAX3 |
| TF name : | FOXD3 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| FOXD3 | POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | reactome | 13 |
| FOXD3 | Hs_Neural_Crest_Differentiation_WP2064_79263 | wikipathways | 40 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_03706 | chr2:223164458-223165065 | skin of body | malignant cell | melanoma |
| E_03810 | chr2:223164458-223164688 | skin | malignant cell | Melanoma |
| E_03812 | chr2:223164458-223164688 | zone of skin | melanoma cell | cutaneous melanoma |
| E_03811 | chr2:223164846-223165065 | skin | malignant cell | Melanoma |
| E_03813 | chr2:223164846-223165065 | zone of skin | melanoma cell | cutaneous melanoma |